A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED)

Phase 4

Completed

• Conditions: Complicated Intra-abdominal Infection

• Registration Number: NCT00157898
• Lead Sponsor: Merck Sharp & Dohme LLC

Brief Summary

This was a prospective, randomized, controlled, open, and multi-center trial conducted to compare the clinical efficacy and safety of ertapenem with it's comparator before or following adequate surgical management of complicated intra-abdominal infection.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-01
• Primary Completion: 2004-08
• Study Completion: 2004-09
• Study First Submitted: 2005-09-07
• Study First Submitted QC: 2005-09-07
• Study First Posted: 2005-09-12
• Status Verified: 2017-02
• Last Update Submitted: 2017-02-17
• Last Update Posted: 2017-02-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 134

Inclusion Criteria

• Males or females between the ages of 18 and 75 who have complicated intra-abdominal infection.

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Favorable clinical response at 7-14 days after treatment

Secondary Outcome Measures

Name	Time	Method
Favorable microbiologic response at 7-14 days after treatment